Previously, Li et al. revealed that ARID1A suppresses the inhibitory effects of the histone methyltransferase EZH2 on the expression of genes encoding T-cell–inducing chemokines, thereby promoting the accumulation of T cells in the vicinity of cancer cells and ultimately suppressing cancer [44]. The gene discussed is PRDM9; the disease is cancer.